Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Has results × Cardiovascular Diseases × Febuxostat × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Tumor Lysis Syndrome 1 Lymphoma 1 Leukemia 1 Inflammation 1 Hyperuricemia 1 Gout 1 Cardiovascular Diseases 1 Arthritis 1

Interventions

Fatty Acids, Omega-3 2 Vorinostat 1 Vitamin E 1 Tumor Necrosis Factor Inhibitors 1 Therapeutics 1 Sugars 1 Rosuvastatin Calcium 1 Omeprazole 1 Nutrition Assessment 1 Naproxen 1 Liraglutide 1 Geritol 1 Fish Oils 1 Febuxostat 1 Desvenlafaxine Succinate 1 Colchicine 1 Cholecalciferol 1 Chocolate 1 Bortezomib 1 Atorvastatin 1 Aspirin 1 Antirheumatic Agents 1 Allopurinol 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02500641 2019-06-21

FORWARD

Menarini International Operations Luxembourg SA

Phase 4 Completed

196 enrolled 9 charts

Arthritis, Cardiovascular Diseases, Gout, Inflammation, Hyperuricemia

Data powered by HemOnc (CC BY 4.0) Colophon ⚡